[DRAFT — Pending medical + legal review]   Every claim on this page requires medical director + healthcare counsel sign-off before publication.
(702) 555-0100 Book Consultation
Home/ Peptide Library/ Thymosin Alpha-1
Immune & Wellness Support  ·  Healthy Aging & Longevity

Thymosin Alpha-1

Thymalfasin, Tα1, Zadaxin (approved in some countries outside the US)

A compounded, investigational immunomodulatory peptide that some providers use as part of a broader plan supporting immune resilience in eligible adults.

Recent Labs Recommended Compounded Subcutaneous injection (as prescribed) Prescription Consultation Required
Provider approval and a live video consultation are required before treatment. Schedule now →

What Is It?

Thymosin Alpha-1 (Tα1) is a synthetic peptide that mirrors a natural product of the thymus gland and has been studied for effects on T-cell development and innate immune signaling. It is approved as a prescription drug (Zadaxin) in several countries outside the United States for specific viral and immune indications. In the United States, thymosin alpha-1 is dispensed as a compounded prescription and is not FDA-approved. Some providers use it as part of a broader plan supporting immune resilience or recovery goals in eligible adults under provider direction.

What May It Support?

  • Immune resilience (being evaluated)
  • Recovery support (being evaluated)
  • Adjunctive support in a broader wellness plan

Which Programs May Include It?

Where It Fits

Being evaluated for effects on T-cell maturation, dendritic-cell function, and innate immune signaling; the full human mechanism in wellness settings is not yet established.

Beginner
Provider-directed use
Intermediate
Provider-directed use
Advanced
Provider-directed use

Do I Need Bloodwork?

Recent Labs Recommended

Follow-up interval and any additional testing are determined by the treating provider.

Likely baseline panel may include: Recent CBC, CMP, and a general wellness panel recommended

Important Safety Information

Common side effects may include:

  • Injection-site reactions
  • Mild fatigue after dosing
  • Occasional headache
  • Rare allergic reaction
Serious WarningsLong-term safety data for wellness use in humans is limited
Not for use in patients on immunosuppressive therapy without provider clearance
Not established for use during pregnancy or breastfeeding

Drug interactions: May interact with immunosuppressants and any medication affecting immune function. Provider must review the complete medication list.

Contraindications:

  • Immunosuppressive therapy without provider clearance
  • Solid-organ transplant recipients (case-by-case)
  • Pregnancy or breastfeeding
  • Known hypersensitivity to thymosin alpha-1 or any product component
Pregnancy & BreastfeedingNot recommended during pregnancy, while trying to conceive, or while breastfeeding.
Cancer-Related ConsiderationsAny personal or family history of cancer should be disclosed to your provider before considering this therapy.

Regulatory Status

Thymosin alpha-1 is not FDA-approved in the United States. It is approved in some other countries (as Zadaxin) for specific viral and immune indications. When prescribed by a US-licensed medical provider, it is dispensed as a compounded prescription.

Compounded MedicationCompounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.

Frequently Asked Questions

How is thymosin alpha-1 taken?
When prescribed, thymosin alpha-1 is typically given as a subcutaneous injection. Dose, frequency, and duration are determined by the treating provider.
Will it prevent illness?
No. Thymosin alpha-1 should not be represented as a preventive treatment for any specific infection or disease. Some providers use it as part of a broader plan supporting immune resilience.
Do I need bloodwork before starting?
Recent laboratory results are recommended so your provider can assess suitability. Additional testing may be ordered based on your history and goals.
Is thymosin alpha-1 right for me?
Because thymosin alpha-1 is a compounded, investigational therapy in the US, eligibility depends on a licensed medical provider's review during a live video consultation.

Consultation

Treatment is not automatically provided. A licensed medical provider must review your history, symptoms, medications, laboratory results, and treatment goals before determining eligibility.

Schedule My Video Consultation
Explore More

Not sure where to start?

Answer a short set of questions about your goals and health history and see educational Beginner, Intermediate, and Advanced pathways your provider may discuss with you.

Not Medical Advice

The information provided on this website is for general educational purposes and is not medical advice, a diagnosis, or a prescription. Treatment recommendations are not final until a licensed medical provider completes a live consultation, reviews your medical history and medications, evaluates relevant laboratory results, and determines that treatment is medically appropriate.

Compounded Medication Disclosure

Certain treatments may be prepared by a compounding pharmacy pursuant to an individual prescription. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing.

Results

Your results identify subjects to discuss with a provider. They do not establish medical eligibility or guarantee that any medication will be prescribed.

Emergencies

This website is not intended for emergencies. Call 911 or seek immediate medical attention for urgent or severe symptoms.